Logo image of CCM

CONCORD MEDICAL - SPON ADR (CCM) Stock Earnings & Estimates

USA - New York Stock Exchange - NYSE:CCM - US2062772049 - ADR

3.86 USD
+0.09 (+2.39%)
Last: 12/31/2025, 8:04:00 PM
4.05 USD
+0.19 (+4.92%)
After Hours: 12/10/2025, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
CCM revenue by date.CCM revenue by date.
472.085M
-2.78%
537M
13.75%
384M
-28.49%
EBITDA
YoY % growth
CCM ebitda by date.CCM ebitda by date.
-392.234M
-10.74%
-381.36M
2.77%
-447M
-17.21%
EBIT
YoY % growth
CCM ebit by date.CCM ebit by date.
-525.048M
-14.56%
-463.36M
11.75%
-532M
-14.81%
Operating Margin
CCM operating margin by date.CCM operating margin by date.
-111.22%-86.29%-138.54%
EPS
YoY % growth
CCM eps by date.CCM eps by date.
N/AN/AN/A

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
CCM Yearly EPS VS EstimatesCCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 2 -2 -4 -6
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
201M
-8.22%
%
Q4 2024
Q2Q % growth
165M
-34.78%
%
Q2 2024
Q2Q % growth
219M
-23.03%
%
Q4 2023
Q2Q % growth
253M
-22.82%
%
Q2 2023
Q2Q % growth
284.513M
97.22%
%
Q4 2022
Q2Q % growth
327.823M
11.98%
%
Q2 2022
Q2Q % growth
144.262M
-25.21%
%
Q4 2021
Q2Q % growth
292.746M
109.10%
%
Q2 2021
Q2Q % growth
192.887M
132.36%
%
CCM Yearly Revenue VS EstimatesCCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A